Opportunity:  Immuno-oncology therapy is promising but under-delivers

Immunotherapy holds great promise for cancer patients, yet today, approximately 80% of patients do not respond to approved immunotherapies. Immunotherapy combinations are widely seen as the best opportunity to significantly increase response rates.

1.7 Million

New Cancer Cases in 2018 in U.S. Alone

600,000+ Deaths

U.S. Cancer Deaths in 2018

#2 Globally

Cancer is the 2nd leading cause of death

8.8 Million

Cancer caused 8.8 million deaths in 2015.

1 of every 6

Nearly 1 in 6 deaths caused by cancer

~500 Trials

500 immunotherapy combo trials as of 2017


Learn how Sonnet is seeking to improve immunotherapy response rates for cancer patients